Whether infants at five months of age look mostly at faces or non-social objects such as cars or mobile phones is largely determined by genes.
Apogee files to go public, unveiling plans to make a play for Dupixent’s turf
Apogee Therapeutics launched last year with $169 million in private financing and is headed for an IPO. The startup was spun out of Paragon Therapeutics